Abstract:Women tend to receive substantially more surgeries than men due mainly to gynecological and cosmetic surgeries. Despite its cosmetic, therapeutic or even life-saving benefits, surgery is reported to increase the cancer risk and promotes cancer metastasis. We have recently shown that surgical stress activates the adrenergic signaling pathway, induces angiogenesis and accelerates the growth of pre-existing endometriotic lesions in mouse. We also have shown that such a facilitory effect of surgery can be completely abrogated by β-blockade. Our hospital-based case-control study also indicates that past open abdominal surgery increases the risk of developing endometriosis by over 3 folds. This study was undertaken to investigate whether perioperative administration of β-blocker and andrographolide (Andro), an NF-κB inhibitor, can abrogate such a facilitory effect. A prospective and randomized mouse experimentation. Fifty-nine female adult Balb/C mice were used for this study, 20 of them serving as donors of endometrial tissues. Three days after the induction of endometriosis by intraperitoneal injection of endometrial fragments after a baseline evaluation of hotplate latency, mice were randomly divided into 4 groups of roughly equal sizes, one served as control receiving saline only, the Andro group that was administrated with Andro, the Prop group that received Propranonol, a non-specific β-blocker, and the Andro+Prop group that received both Prop and Andro treatment. One hour after the drug administration, a simulated open abdominal surgery was performed. One day after the surgery, all mice received the second treatment. Two weeks after the surgery, all mice were sacrificed, their lesion size and hotplate latency evaluated and endometriotic tissue samples harvested for immunohistochemistry analysis of β2-adrenergic receptor (ADRB2), phosphorylated cAMP responsive element-binding protein (p-CREB), vascular endothelial growth factor (VEGF), CD31-positive microvessels, and proliferating cell nuclear antigen (PCNA). Perioperative administration of β-blocker completely abrogated the facilitory effect of surgery on lesion growth and the generalized hyperalgesia. Andro showed some inhibitory effect, but the results did not reach statistical significance. Both Prop and Andro significantly reduced the expression of ADRB2, p-CREB, VEGF, and PCNA and the microvessel density in endometriotic lesions. Our data indicate that perioperative administration of β-blocker, and perhaps Andro as well, can abrogate the surgery-induced acceleration of endometriosis development in mouse. These findings warrant clinical studies of β-blockade in patients undergoing various surgery in order to forestall the development of endometriosis and perhaps also to reduce the recurrence risk. in endometriosis.

Preoperative and perioperative intervention reduces the risk of recurrence of endometriosis in mice caused by either incomplete excision or spillage and dissemination

Perioperative Intervention by Β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision.

EFFICACY OF GOSERELIN FOR POST-OPERATIVE TREATMENT IN CHINESE PATIENTS WITH MODERATE TO SEVERE ENDOMETRIOSIS: AN OBSERVATIONAL, MULTICENTRE, OPEN-LABEL, NON-INTERVENTIONAL STUDY

Perioperative Treatment with Beta-Blocker and Andrographolide Abrogates Surgery-Induced Acceleration of Endometriosis Development in Mouse

The perioperative period: a critical yet neglected time window for reducing the recurrence risk of endometriosis?

Upregulation of H-Tert and Ki-67 in Ectopic Endometrium is Associated with Recurrence of Endometriosis

Effect of PRL-3 inhibitor on the ectopic lesions in rats with endometriosis

Progress of Laparoscopic Surgery for Deep Infiltrating Endometriosis

Is Nerve-Sparing Surgery Suitable for Deeply Infiltrating Endometriosis?

The efficacy and safety of up to 24 weeks of triptorelin therapy following conservative surgery in patients with deep infiltrating endometriosis (DIE): a multicentre, prospective, non-interventional study in China

Adenomyosis in mice resulting from mechanically or thermally induced endometrial–myometrial interface disruption and its possible prevention

Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial–Myometrial Interface Disruption in Mice

Chinese Medicinal Plants for Advanced Endometriosis after Conservative Surgery: A Prospective, Multi-Center and Controlled Trial

Preclinical testing of RRx-001 in mouse models of experimental endometriosis reveals promising therapeutic impacts

Surgery Accelerates the Development of Endometriosis in Mice.

Trichostatin A, A Histone Deacetylase Inhibitor, Reduces Lesion Growth and Hyperalgesia in Experimentally Induced Endometriosis in Mice

Antibiotic Therapy and Vaginal Microbiota Transplantation Reduce Endometriosis Disease Progression in Female Mice via NF-κB Signaling Pathway

Scutellarin Suppresses Platelet Aggregation and Stalls Lesional Progression in Mouse with Induced Endometriosis

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway

Assessment of Risk Factors Associated with Severe Endometriosis and Establishment of Preoperative Prediction Model